Thirty-five per cent (13 of 37) of newborns, studied at less than 2 weeks of age, with congenital heart lesions, had abnormally high serum levels of both IgM (>20 mg/Ioo ml) and anti-heart IgM demonstrable by a fluorescent technique. An association between the raised serum IgM, reflecting in utero infection, and the congenital heart defects may be deduced. Possible explanations of the presence of anti-heart IgM in the sera of these newborns include modification of the antigenicity of the developing heart with teratogenic effect produced by the invading organism, but not the anti-heart IgM; and direct teratogenic influence of the anti-heart antibody offetal origin raised against both the invading organism and shared (or modified) antigens in the host.
Of the dozen viruses which can reach the fetus, 3 or possibly 4 have been associated with congenital malformations to the extent that they may be considered to be teratogenic (rubella virus, cytomegalovirus, Herpes virus hominis, and possibly Coxsackie B viruses). Raised levels of IgM have been found in the cord blood of newborns with congenital rubella and cytomegalic inclusion disease and have been taken as evidence of in utero infection with fetal synthesis of antibody (Sever, I969) , because the size of the IgM macroglobulin does not permit placental transfer from the mother to the fetus under normal conditions.
The mechanism by which viruses may cause maldevelopment are not completely understood. Rubella virus in the human is probably teratogenic through a direct virus-host cell interaction. For a virus to cause maldevelopment the infection must occur at a vulnerable period of embryogenesis, usually in the first trimester. And for a virus to cause fetal synthesis of IgM, immunologically responsive tissue must be present. The development of thymic and lymphoid tissues occurs at about the same time as development of the heart. Antibodies against kidney (Brent, I964) have been documented to have a generalized teratogenic effect producing multiple anomalies in experimental animals. Anti-heart antibody appears to have both a generalized and organ-specific effect (Nora, I97I) Received 30 July I973.
1 Supported by a grant from the American Heart Association and a grant from the National Heart and Lung Institute. in that there is a significantly higher frequency of cardiovascular anomalies produced by anti-heart antibody than by anti-kidney antibody. Anti-heart antibody is detectable by immunofluorescent staining techniques, which have also shown crossreaction between antigens of heart of several mammalian species, human skeletal muscle, and the phylogenetically distant Group A streptococci (Kaplan, Meyeserian, and Kushner, I96I; Kaplan and Meyeserian, I962) .
Subjects and methods
Blood was obtained from newborns, 2 weeks of age or less, with congenital heart lesions, who have been studied at cardiac catheterization, to look for increases in IgM and to determine the presence in their serum of anti-heart IgM by immunofluorescent staining. A control group of 30 newborns without heart defects was obtained from the same medical centre population and matched for race, age, and socioeconomic level.
Quantitative IgM levels were obtained by a modification of the single radial diffusion technique of Mancini, Carbonara, and Heremans (x965) 
Results
As recorded in Table I , i6 of 38 newborns (41%) aged i to I2 days who had congenital heart defects had increases of IgM greater than 20 mg/ioo ml. Of the 30 newborns (aged I to 12 days) in the control group, only 2 had IgM levels greater than 20 mg/ioo ml. Only increases which persisted in In Table 2 , one patient has been eliminated who had a quantitative IgM determination (>20mg/ ioo ml), but on whom no fluorescent anti-heart IgM study was obtained. This Table reveals that I3 newborns (of the IS congenital heart patients who had raised levels of IgM and a fluorescent antiheart antibody study) also had fluorescent antiheart IgM in their sera. None of the 30 control patients had anti-heart IgM, though 2 control patients had raised serum levels of IgM. This difference is significant at the o ooi level. Two newborns who had congenital heart lesions and increases of IgM did not have evidence of anti-heart IgM by fluorescent studies. Table 3 records the heart lesions and the ages of the patients at the time of the study. There is nothing unusual about the types of lesions encountered. These are typical of the defects requiring cardiac catheterization before 2 weeks of age. What is noteworthy is that transposition of the great vessels appears 4 times and truncus arteriosus once, indicating that the teratogenic insult 
Discussion
There are various possible interpretations of these findings. To begin with there is a highly significant association between evidence for in utero infection and the cardiovascular malformations found in the newborns, though there is no demonstrable causal relation. In the case of rubella, the association between viral infection and congenital heart disease is well established. The high frequency with which high levels of IgM were found in these newborns is provocative and justifies further investigation of congenital heart patients in a search for specific viral agents.
The demonstration of fluorescent anti-heart IgM in the sera of I3 newborns with congenital heart defects who had raised serum levels of IgM may mean that a presumed in utero infection continued through the periods of development of the heart and thymic-lymphoid system and eventually called forth an antibody response. This was detectable as anti-heart IgM, though neither the anti-heart antibody nor the in utero infections played teratogenic roles in the maldevelopment of the cardiovascular systems of these newborns.
A more positive and equally plausible explanation is that the infection played a teratogenic role through a mechanism such as direct virus-host cell interaction, but that the anti-heart IgM itself had no teratogenic influence. A corollary of this could be that the infecting organism modified the antigenicity of the developing heart so that when the fetus became immune-competent, it recognized the heart as 'non-self' and raised antibody against it (anti-heart IgM). This explanation would be most consistent with available evidence, and the presence of anti-heart IgM would add further aetiological significance to the high IgM levels.
Yet another explanation is that the anti-heart antibody, raised against the invading organism and shared, or modified, antigens in the host, was teratogenic to the developing heart. Present limitations in our knowledge of immunological development in the human permit us considerable latitude for speculation. The specificity of anti-heart antibody for heart alone has not been demonstrated by us or other investigators. Cross-reaction with skeletal muscle has been shown by Kaplan and Meyeserian (I962) and was found by us in a study of cardiac transplant patients using the same conjugates and methods employed in this investigation (Rossen et al., 197I) . There is experimental evidence for generalized as well as organ-specific teratogenicity of antibody raised against kidney, heart, and more discrete protein components of tissues (Langman, I964) . Our experiments with anti-heart antibody in the mouse show it to be one of the most potent teratogens we have used to produce cardiovascular maldevelopment and suggest that anti-heart anti-body has greater specificity for the heart than antikidney antibody (Nora, I97I) .
Small lymphocytes have been seen to appear in the peripheral blood of the human fetus as early as 7 weeks' gestation (Playfair, Wolfendale, and Kay, I963) . During the 7th week of gestation lymphocytes also migrate to the thymic primordia (ValdesDapena, 1957) . Immune competence of these cells as early as this in the human has not been demonstrated, but immune responsiveness in the sheep has been documented even before the appearance of thymic and lymphoid tissue (Silverstein, I969) . Given the demonstrable teratogenicity of anti-heart antibody to the developing mammalian heart, the presence of potentially immune competent tissue in the human fetus at a stage of organogenesis when anti-heart antibody could exercise teratogenic influence, and the detection of both raised serum levels of IgM and fluorescent anti-heart IgM in newborns with congenital heart lesions, the proposal that anti-heart antibody of fetal origin may be teratogenic to the developing human heart is a possibility which should be investigated further.
Certainly, virus-host cell interaction is most likely to be the teratogenic mechanism of cardiovascular maldevelopment in our patients. However, autoimmune host reponse to an infecting organism remains a possible alternative in some patients.
